- Home
- RYAM vs THRD Comparison
RYAM vs THRD Comparison
Compare RYAM & THRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYAM
- THRD
- Stock Information
- Founded
- RYAM 1926
- THRD 2019
- Country
- RYAM United States
- THRD United States
- Employees
- RYAM N/A
- THRD N/A
- Industry
- RYAM Paper
- THRD Biotechnology: Pharmaceutical Preparations
- Sector
- RYAM Basic Materials
- THRD Health Care
- Exchange
- RYAM Nasdaq
- THRD Nasdaq
- Market Cap
- RYAM 577.2M
- THRD 513.2M
- IPO Year
- RYAM N/A
- THRD 2022
- Fundamental
- Price
- RYAM $8.88
- THRD $12.47
- Analyst Decision
- RYAM Buy
- THRD Strong Buy
- Analyst Count
- RYAM 1
- THRD 3
- Target Price
- RYAM $12.00
- THRD $20.33
- AVG Volume (30 Days)
- RYAM 655.6K
- THRD 233.9K
- Earning Date
- RYAM 11-05-2024
- THRD 11-07-2024
- Dividend Yield
- RYAM N/A
- THRD N/A
- EPS Growth
- RYAM N/A
- THRD N/A
- EPS
- RYAM N/A
- THRD N/A
- Revenue
- RYAM $1,630,290,000.00
- THRD N/A
- Revenue This Year
- RYAM $0.53
- THRD N/A
- Revenue Next Year
- RYAM $2.60
- THRD N/A
- P/E Ratio
- RYAM N/A
- THRD N/A
- Revenue Growth
- RYAM N/A
- THRD N/A
- 52 Week Low
- RYAM $3.02
- THRD $7.08
- 52 Week High
- RYAM $10.28
- THRD $16.94
- Technical
- Relative Strength Index (RSI)
- RYAM 51.42
- THRD 46.72
- Support Level
- RYAM $8.79
- THRD $10.10
- Resistance Level
- RYAM $10.28
- THRD $12.49
- Average True Range (ATR)
- RYAM 0.40
- THRD 1.23
- MACD
- RYAM -0.07
- THRD -0.25
- Stochastic Oscillator
- RYAM 36.94
- THRD 43.89
About RYAM Rayonier Advanced Materials Inc.
Rayonier Advanced Materials Inc manufactures high-purity cellulose derived from wood. Also known as cellulose specialties, the company's products are used in a variety of applications, including cigarette filters, liquid crystal displays, paints, pharmaceuticals, and food. The company operates in the reportable segments of High Purity Cellulose, Paperboard, High-Yield Pulp, and Corporate and Other. The key revenue is derived from the High Purity Cellulose segment. Geographically, it derives a majority of revenue from the United States.
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.